Advisory Services Network, LLC Ironwood Pharmaceuticals Inc Transaction History

Advisory Services Network, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$8.79 - $11.51 $18,617 - $24,378	2,118 New	2,118 $24,000
Q1 2023 May 17, 2023	SELL	$10.37 - $12.56 $3,940 - $4,772	-380 Reduced 12.61%	2,633 $27,000
Q4 2022 Feb 13, 2023	BUY	$9.9 - $12.43 $29,828 - $37,451	3,013 New	3,013 $37,000
Q3 2021 Nov 05, 2021	SELL	$11.92 - $13.92 $1,192 - $1,392	-100 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$10.16 - $13.11 $1,016 - $1,311	100 New	100 $1,000
Q1 2021 May 24, 2021	SELL	$9.04 - $11.86 $903 - $1,186	-100 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$9.05 - $12.2 $45 - $61	-5 Reduced 4.76%	100 $1,000
Q3 2020 Nov 16, 2020	BUY	$8.99 - $10.74 $943 - $1,127	105 New	105 $1,000
Q2 2020 Aug 10, 2020	SELL	$9.14 - $11.97 $914 - $1,197	-100 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$8.58 - $14.01 $858 - $1,401	100 New	100 $1,000

237

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $682M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.